Correlation Between WSFS Financial and Transcode Therapeutics
Can any of the company-specific risk be diversified away by investing in both WSFS Financial and Transcode Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining WSFS Financial and Transcode Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between WSFS Financial and Transcode Therapeutics, you can compare the effects of market volatilities on WSFS Financial and Transcode Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in WSFS Financial with a short position of Transcode Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of WSFS Financial and Transcode Therapeutics.
Diversification Opportunities for WSFS Financial and Transcode Therapeutics
-0.59 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between WSFS and Transcode is -0.59. Overlapping area represents the amount of risk that can be diversified away by holding WSFS Financial and Transcode Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Transcode Therapeutics and WSFS Financial is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on WSFS Financial are associated (or correlated) with Transcode Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Transcode Therapeutics has no effect on the direction of WSFS Financial i.e., WSFS Financial and Transcode Therapeutics go up and down completely randomly.
Pair Corralation between WSFS Financial and Transcode Therapeutics
Given the investment horizon of 90 days WSFS Financial is expected to generate 0.23 times more return on investment than Transcode Therapeutics. However, WSFS Financial is 4.26 times less risky than Transcode Therapeutics. It trades about 0.0 of its potential returns per unit of risk. Transcode Therapeutics is currently generating about -0.01 per unit of risk. If you would invest 5,725 in WSFS Financial on October 17, 2025 and sell it today you would lose (6.00) from holding WSFS Financial or give up 0.1% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
WSFS Financial vs. Transcode Therapeutics
Performance |
| Timeline |
| WSFS Financial |
| Transcode Therapeutics |
WSFS Financial and Transcode Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with WSFS Financial and Transcode Therapeutics
The main advantage of trading using opposite WSFS Financial and Transcode Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if WSFS Financial position performs unexpectedly, Transcode Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Transcode Therapeutics will offset losses from the drop in Transcode Therapeutics' long position.| WSFS Financial vs. First Financial Bancorp | WSFS Financial vs. Provident Financial Services | WSFS Financial vs. Washington Federal | WSFS Financial vs. Banner |
| Transcode Therapeutics vs. In8bio Inc | Transcode Therapeutics vs. Lyra Therapeutics | Transcode Therapeutics vs. Aptevo Therapeutics | Transcode Therapeutics vs. Galecto |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.
Other Complementary Tools
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity |